These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

551 related items for PubMed ID: 16911693

  • 1. Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease.
    Kaneda H, Hashimoto E, Yatsuji S, Tokushige K, Shiratori K.
    J Gastroenterol Hepatol; 2006 Sep; 21(9):1459-65. PubMed ID: 16911693
    [Abstract] [Full Text] [Related]

  • 2. Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease.
    Suzuki A, Angulo P, Lymp J, Li D, Satomura S, Lindor K.
    Liver Int; 2005 Aug; 25(4):779-86. PubMed ID: 15998429
    [Abstract] [Full Text] [Related]

  • 3. Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease.
    Miele L, Forgione A, La Torre G, Vero V, Cefalo C, Racco S, Vellone VG, Vecchio FM, Gasbarrini G, Rapaccini GL, Neuman MG, Grieco A.
    Transl Res; 2009 Oct; 154(4):194-201. PubMed ID: 19766963
    [Abstract] [Full Text] [Related]

  • 4. Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease.
    Lebensztejn DM, Wierzbicka A, Socha P, Pronicki M, Skiba E, Werpachowska I, Kaczmarski M.
    Acta Biochim Pol; 2011 Oct; 58(4):563-6. PubMed ID: 22140659
    [Abstract] [Full Text] [Related]

  • 5. Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease.
    Nobili V, Alisi A, Torre G, De Vito R, Pietrobattista A, Morino G, De Ville De Goyet J, Bedogni G, Pinzani M.
    Transl Res; 2010 Oct; 156(4):229-34. PubMed ID: 20875899
    [Abstract] [Full Text] [Related]

  • 6. Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis.
    Miyaaki H, Ichikawa T, Nakao K, Yatsuhashi H, Furukawa R, Ohba K, Omagari K, Kusumoto Y, Yanagi K, Inoue O, Kinoshita N, Ishibashi H, Yano M, Eguchi K.
    Liver Int; 2008 Apr; 28(4):519-24. PubMed ID: 17976158
    [Abstract] [Full Text] [Related]

  • 7. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
    McPherson S, Stewart SF, Henderson E, Burt AD, Day CP.
    Gut; 2010 Sep; 59(9):1265-9. PubMed ID: 20801772
    [Abstract] [Full Text] [Related]

  • 8. Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk.
    Tahan V, Canbakan B, Balci H, Dane F, Akin H, Can G, Hatemi I, Olgac V, Sonsuz A, Ozbay G, Yurdakul I, Senturk H.
    Hepatogastroenterology; 2008 Sep; 55(85):1433-8. PubMed ID: 18795706
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
    Park JH, Park CK, Kim ES, Park SY, Jo CM, Tak WY, Kweon YO, Kim SK, Choi YW.
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
    [Abstract] [Full Text] [Related]

  • 13. Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease.
    Adams LA, George J, Bugianesi E, Rossi E, De Boer WB, van der Poorten D, Ching HL, Bulsara M, Jeffrey GP.
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1536-43. PubMed ID: 21950746
    [Abstract] [Full Text] [Related]

  • 14. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
    Ding XJ, Li SB, Li SZ, Liu HS, Liu B, Xu FM, Gu RW.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
    [Abstract] [Full Text] [Related]

  • 15. Serum hyaluronic acid for the screening of progressive nonalcoholic steatohepatitis in children: a promising approach.
    Valenti L, Dongiovanni P.
    Transl Res; 2010 Oct; 156(4):226-8. PubMed ID: 20875898
    [Abstract] [Full Text] [Related]

  • 16. Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease.
    Alkhouri N, Sedki E, Alisi A, Lopez R, Pinzani M, Feldstein AE, Nobili V.
    Liver Int; 2013 Jan; 33(1):79-85. PubMed ID: 23146095
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Non-invasive model predicting clinically-significant portal hypertension in patients with advanced fibrosis.
    Park SH, Park TE, Kim YM, Kim SJ, Baik GH, Kim JB, Kim DJ.
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1289-93. PubMed ID: 19682196
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.